Cargando…

Classic psychedelics, health behavior, and physical health

BACKGROUND: Preliminary evidence suggests that classic psychedelics may be effective in the treatment of some psychiatric disorders, yet little remains known about their effects on health behavior and physical health. OBJECTIVES: The purpose of this study was to investigate associations of lifetime...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simonsson, Otto, Hendricks, Peter S., Chambers, Richard, Osika, Walter, Goldberg, Simon B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	From Drug Misuse to Useful Drugs
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716448/ https://www.ncbi.nlm.nih.gov/pubmed/36465958 http://dx.doi.org/10.1177/20451253221135363

Ejemplares similares

The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics
por: Evens, Ricarda, et al.
Publicado: (2023)

The therapeutic potential of microdosing psychedelics in depression
por: Kuypers, Kim P.C.
Publicado: (2020)

Psychedelic treatment of functional neurological disorder: a systematic review
por: Butler, Matthew, et al.
Publicado: (2020)

History repeating: guidelines to address common problems in psychedelic science
por: van Elk, Michiel, et al.
Publicado: (2023)

Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study
por: Glue, Paul, et al.
Publicado: (2020)

Ketamine for bipolar depression: an updated systematic review
por: Fancy, Farhan, et al.
Publicado: (2023)

Cannabidiol as a potential treatment for psychosis
por: Davies, Cathy, et al.
Publicado: (2019)

Improvement of functional neurological disorder after administration of esketamine nasal spray: a case report
por: Vendrell-Serres, Júlia, et al.
Publicado: (2021)

Will psilocybin lose its magic in the clinical setting?
por: Hayes, Caroline, et al.
Publicado: (2022)

Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine
por: O’Shaughnessy, David M., et al.
Publicado: (2021)

Associations between lifetime classic psychedelic use and cardiometabolic diseases
por: Simonsson, Otto, et al.
Publicado: (2021)

Associations between lifetime classic psychedelic use and markers of physical health
por: Simonsson, Otto, et al.
Publicado: (2021)

Classic Psychedelics and Human–Animal Relations
por: Pöllänen, Elin, et al.
Publicado: (2022)

Lifecourse SEP and tobacco and cannabis use
por: Bowes, Lucy, et al.
Publicado: (2013)

Altered states of leadership: mindfulness meditation, psychedelic use, and leadership development
por: Simonsson, Otto, et al.
Publicado: (2023)

Factors associated with changing alcohol consumption during the first UK lockdown
por: McAloney-Kocaman, Kareena, et al.
Publicado: (2022)

Alcohol use in adolescence as a risk factor for overdose in the 1986 Northern Finland Birth Cohort Study
por: Koivisto, Maarit K, et al.
Publicado: (2022)

Increasing prevalence of illicit drug use among employees at Swedish workplaces over a 25-year period
por: Feltmann, Kristin, et al.
Publicado: (2022)

Evidence of the emergence of illicit benzodiazepines from online drug forums
por: Sarker, Abeed, et al.
Publicado: (2022)

Parental alcohol and drug abuse and offspring mortality by age 10: a population-based register study
por: Berg, Venla, et al.
Publicado: (2022)

Disentangling the association between alcohol consumption and employment status: causation, selection or confounding?
por: Mangot-Sala, Lluís, et al.
Publicado: (2022)

Anti-VEGF drugs in the prevention of blindness
por: Yorston, David
Publicado: (2014)

Anti-VEGF treatment for acute ROP – not yet recommended!
por: Gilbert, Clare
Publicado: (2014)

The Situation of Chemokine Ligands and Receptors Gene Expression, Following the Oral Administration of Drug Mannuronic Acid in Rheumatoid Arthritis Patients
por: Aslani, Mona, et al.
Publicado: (2020)

Chitinases: Therapeutic Scaffolds for Allergy and Inflammation
por: Madan, Kirtika, et al.
Publicado: (2020)

Onychomycosis: An Updated Review
por: Leung, Alexander K.C., et al.
Publicado: (2020)

Anti-Inflammatory and Gastroprotective Properties of Aspirin - Entrapped Solid Lipid Microparticles
por: Chime, Salome A., et al.
Publicado: (2020)

Comparative efficacy of generic nifedipine versus brand‐name amlodipine for hypertension management in Taiwan
por: Lee, Hao‐Wei, et al.
Publicado: (2022)

An open-label study to estimate the effect of steady-state erythromycin on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban in subjects with renal impairment and normal renal function
por: Moore, Kenneth T, et al.
Publicado: (2014)

Magnocaine: Physical Compatibility and Chemical Stability of Magnesium Sulphate and Lidocaine Hydrochloride in Prefilled Syringes
por: Houlihan, Sara, et al.
Publicado: (2016)

Pregabalin-induced self-harm behavior
por: Tandon, Vishal R, et al.
Publicado: (2013)

The contribution of Nintendo Wii Fit series in the field of health: a systematic review and meta-analysis
por: Tripette, Julien, et al.
Publicado: (2017)

Alternative beliefs in psychedelic drug users
por: Lebedev, Alexander V., et al.
Publicado: (2023)

Mucoactive agent use in adult UK Critical Care Units: a survey of health care professionals’ perception, pharmacists’ description of practice, and point prevalence of mucoactive use in invasively mechanically ventilated patients
por: Borthwick, Mark, et al.
Publicado: (2020)

Targeting β(3)-Adrenergic Receptors in the Heart: Selective Agonism and β-Blockade
por: Cannavo, Alessandro, et al.
Publicado: (2017)

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
por: Ballantyne, Christie M, et al.
Publicado: (2019)

The impact of co-administration of ketoconazole and rifampicin on the pharmacokinetics of apremilast in healthy volunteers
por: Liu, Yong, et al.
Publicado: (2014)

Building interpretable models for polypharmacy prediction in older chronic patients based on drug prescription records
por: Kocbek, Simon, et al.
Publicado: (2018)

In Vivo Assessment of the Effect of CYP1A2 Inhibition and Induction on Pomalidomide Pharmacokinetics in Healthy Subjects
por: Li, Yan, et al.
Publicado: (2018)

Implantable Cardiac Electronic Devices in the Elderly Population
por: Lim, Wei-Yao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_spsc2h7dg6dbk8j99j0u753n37